Basics RAPT Therapeutics, Inc. IPO Date: October 28, 2019 Sector: Healthcare Industry: Biotech Market Cap: $213.83M Activated in VL: True Average Daily Range Avg Daily Range: $0.71 | 4.00% Avg Daily Range (30 D): $0.53 | 4.73% Avg Daily Range (90 D): $0.33 | 5.32% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .07M Avg Daily Volume (90 D): .34M Trade Size Avg Trade Size (Sh.): 96 Avg Trade Size (Sh.) (30 D): 113 Avg Trade Size (Sh.) (90 D): 180 Institutional Trades Total Inst.Trades: 1,061 Avg Inst. Trade: $1.64M Avg Inst. Trade (30 D): $2.68M Avg Inst. Trade (90 D): $2.77M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.59M Avg Closing Trade (30 D): $3.2M Avg Closing Trade (90 D): $3.2M Avg Closing Volume: 10.97K     News Jun 23, 2025 @ 12:00 PM RAPT Therapeutics Names Two Industry Veterans to i... Source: Rapt Therapeutics, Inc. Jan 6, 2025 @ 1:00 PM RAPT Therapeutics Names Lori Lyons-Williams Cha... Source: Rapt Therapeutics, Inc. Jul 19, 2024 @ 2:00 PM Agenus (AGEN) Tanks on Colorectal Cancer Study Int... Source: N/A Jul 17, 2024 @ 2:01 PM Arcutis (ARQT) Stock Rises 31% in the Past Month: ... Source: Zacks Equity Research Jul 16, 2024 @ 2:30 PM Lisata (LSTA) Stock Rallies More Than 30% YTD: Her... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.65 $-.08 $-1.22 Diluted EPS $-.65 $-.08 $-1.22 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -17.64M $ -17.17M $ -53.25M Operating Income / Loss $ -19.54M $ -19.27M $ -54.47M Cost of Revenue $ $ $ Net Cash Flow $ -127.85M $ M $ 131.84M PE Ratio     Splits Jun 17, 2025:   1:8